Louise Bordeleau

Summary

Affiliation: Mount Sinai Hospital
Country: Canada

Publications

  1. ncbi request reprint Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review
    Louise Bordeleau
    Department of Medical Oncology, University of Toronto, Toronto, Ontario, Canada
    Clin Ther 29:230-41. 2007
  2. doi request reprint Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients
    Sophie Kim
    Department of Pharmacy, Princess Margaret Hospital, Toronto, Canada
    J Oncol Pharm Pract 18:311-5. 2012
  3. ncbi request reprint Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data
    Louise Bordeleau
    Department of Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
    J Clin Oncol 21:1944-51. 2003
  4. doi request reprint Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer
    Seema Panchal
    University of Toronto, Toronto, Ontario, Canada
    Nat Rev Clin Oncol 6:604-7. 2009
  5. pmc Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
    Louise Bordeleau
    Juravinski Cancer Centre, Hamilton, Ontario, Canada
    Cancer 117:1812-8. 2011
  6. doi request reprint A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab
    Sophie Kim
    Department of Pharmacy, Princess Margaret Hospital, Toronto, ON, Canada
    J Oncol Pharm Pract 18:293-5. 2012
  7. doi request reprint Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial
    Angela M Cheung
    University Health Network, University of Toronto, Toronto, ON, Canada
    Lancet Oncol 13:275-84. 2012
  8. doi request reprint Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: a feasibility study
    Daphne Tsoi
    Department of Medical Oncology, Sunnybrook Odette Cancer Centre, The University of Toronto, 2075 Bayview Ave, Toronto, Ontario, Canada
    Breast 20:96-8. 2011
  9. ncbi request reprint Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer
    Reuben J Broom
    Princess Margaret Hospital, Toronto, Canada
    Anticancer Res 29:1557-62. 2009
  10. ncbi request reprint Treating dural metastases mimicking intracranial hypotension
    Daniel Grabarz
    J Support Oncol 5:423-4. 2007

Detail Information

Publications10

  1. ncbi request reprint Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review
    Louise Bordeleau
    Department of Medical Oncology, University of Toronto, Toronto, Ontario, Canada
    Clin Ther 29:230-41. 2007
    ..Because of the contribution of sex hormones to breast cancer, the use of hormonal agents for the control of hot flashes is problematic in these women. Safer nonhormonal alternatives are recommended for this patient group...
  2. doi request reprint Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients
    Sophie Kim
    Department of Pharmacy, Princess Margaret Hospital, Toronto, Canada
    J Oncol Pharm Pract 18:311-5. 2012
    ..We present five cases of chemotherapy-induced infiltrative pneumonitis in breast cancer patients involving docetaxel, paclitaxel, gemcitabine and cyclophosphamide...
  3. ncbi request reprint Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data
    Louise Bordeleau
    Department of Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
    J Clin Oncol 21:1944-51. 2003
    ..To evaluate the effect of a standardized group psychosocial intervention on health-related quality of life (HrQOL) in women with metastatic breast cancer and to explore the effect of missing data in HrQOL analyses...
  4. doi request reprint Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer
    Seema Panchal
    University of Toronto, Toronto, Ontario, Canada
    Nat Rev Clin Oncol 6:604-7. 2009
    ..Aside from notable gynecomastia, he remained asymptomatic. He has a strong family history of breast cancer with multiple sisters affected...
  5. pmc Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
    Louise Bordeleau
    Juravinski Cancer Centre, Hamilton, Ontario, Canada
    Cancer 117:1812-8. 2011
    ..Hyperinsulinemia and the metabolic syndrome are both risk factors for breast cancer. It is not clear if diabetes is associated with the risk of breast cancer in women with a BRCA1 or BRCA2 mutation...
  6. doi request reprint A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab
    Sophie Kim
    Department of Pharmacy, Princess Margaret Hospital, Toronto, ON, Canada
    J Oncol Pharm Pract 18:293-5. 2012
    ..Both dexamethasone and the total lymphocyte nadir predisposed this patient to PJP...
  7. doi request reprint Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial
    Angela M Cheung
    University Health Network, University of Toronto, Toronto, ON, Canada
    Lancet Oncol 13:275-84. 2012
    ..Exemestane can prevent breast cancer in postmenopausal women. Because of potential widespread use, we examined the safety of exemestane on bone health...
  8. doi request reprint Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: a feasibility study
    Daphne Tsoi
    Department of Medical Oncology, Sunnybrook Odette Cancer Centre, The University of Toronto, 2075 Bayview Ave, Toronto, Ontario, Canada
    Breast 20:96-8. 2011
    ..58% agreed to consider participating in the proposed RCT; 16% remained neutral. An RCT of MRI surveillance for BC survivors <age 60 is still feasible at centres where annual MRI is not yet routinely recommended...
  9. ncbi request reprint Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer
    Reuben J Broom
    Princess Margaret Hospital, Toronto, Canada
    Anticancer Res 29:1557-62. 2009
    ..Changes in the receptor profile between primary and metastatic breast cancer tissue have been suggested. The degree of hormone receptor discordance in archival paired pathological samples was evaluated...
  10. ncbi request reprint Treating dural metastases mimicking intracranial hypotension
    Daniel Grabarz
    J Support Oncol 5:423-4. 2007